Cellectar Biosciences (CLRB) PT Lowered to $15 at Ladenburg Thalmann

November 8, 2022 6:34 AM EST
Get Alerts CLRB Hot Sheet
Price: $2.60 +4.84%

Rating Summary:
    6 Buy, 1 Hold, 0 Sell

Rating Trend: Up Up

Today's Overall Ratings:
    Up: 13 | Down: 14 | New: 11
Join SI Premium – FREE
Ladenburg Thalmann analyst Ahu Demir lowered the price target on Cellectar Biosciences (NASDAQ: CLRB) to $15.00 (from $50.00) while maintaining a Buy rating.

You May Also Be Interested In





Related Categories

Analyst PT Change